Quantum Computing Inc. Common
QUBT
$9.02
+8.94%
Quantum Computing Inc. is an integrated photonics and non-linear quantum optics company focused on developing and delivering machines for quantum computing, reservoir computing, and remote sensing, imaging, and cybersecurity applications. The company positions itself as a niche player aiming to commercialize quantum hardware that operates at room temperature and low power at an affordable cost, differentiating itself from competitors requiring cryogenic systems. The current investor narrative is dominated by a speculative sector-wide rally in 2026, fueled by news of accelerated commercial timelines from tech giants like Microsoft and advancements in AI for quantum error correction, which has ignited debate over whether the company's explosive valuation is justified by its nascent revenue and significant long-term commercialization risks.…
QUBT
Quantum Computing Inc. Common
$9.02
Related headlines
Investment Opinion: Should I buy QUBT Today?
Rating: Sell. The core thesis is that QUBT's current $1.69 billion valuation is completely disconnected from its fundamental reality of negligible revenue, deep losses, and heavy cash burn, representing one of the most extreme speculative bubbles in the public markets with a high probability of substantial capital destruction for investors.
The supporting evidence is overwhelming: a trailing PS ratio of 2,474.6x is indefensible; quarterly revenue of $198K shows no meaningful commercial scale; the company burns over $36 million in cash annually with a gross margin of -49.5% in Q4 2025; and the stock is in a persistent long-term downtrend, underperforming the S&P 500 by 47.85 percentage points over six months. While a few analysts maintain 'Buy' ratings, there is no broad consensus or price target to provide a fundamental anchor for upside.
The thesis would be invalidated only if QUBT were to announce a transformative, multi-million dollar commercial contract or a breakthrough partnership that immediately validates its technology and revenue model, leading to a sustained fundamental re-rating. This Hold rating would upgrade to a speculative Buy only if the stock price fell to a level where the market cap more closely reflected its asset value (e.g., near cash), or if quarterly revenue sustainably exceeded $5 million. The stock is profoundly overvalued relative to any rational measure of its current financial performance and near-term prospects.
Sign up to view all
QUBT 12-Month Price Forecast
The investment case for QUBT is overwhelmingly negative. The stock is a pure narrative-driven speculation trading at a valuation that implies near-perfect execution of a highly uncertain technology over a decade or more. The fundamental picture—characterized by trivial revenue, massive losses, and heavy cash burn—provides no support for the current price. The recent 22% monthly bounce is a common feature in volatile downtrends and is unlikely to be sustained. The stance would only upgrade to neutral if the company demonstrated a clear, near-term path to generating $10M+ in annual recurring revenue without excessive dilution. The high probability bear case suggests significant downside risk over the next 12 months.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Quantum Computing Inc. Common's 12-month outlook, with a consensus price target around $11.73 and implied upside of +30.0% versus the current price.
Average Target
$11.73
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$7 - $12
Analyst target range
Analyst coverage for QUBT is limited, with only one analyst providing estimates according to the data, which is typical for a small-cap, pre-revenue technology company and leads to higher volatility and less efficient price discovery. The single analyst provides an estimated EPS average of $1.90 for an unspecified future period, with a range from $1.46 to $2.36, but no consensus price target or recommendation distribution is available, preventing a calculation of implied upside or downside from the current price. The institutional ratings data shows a pattern of maintained 'Buy' ratings from firms like Rosenblatt and Ascendiant Capital alongside a maintained 'Neutral' from Cantor Fitzgerald, with the most recent actions in March 2026, indicating a bifurcated view among the few covering firms; however, the absence of a broad analyst consensus with price targets underscores the highly speculative and narrative-driven nature of the investment case, where traditional fundamental analysis provides little guidance.
Bulls vs Bears: QUBT Investment Factors
The bear case currently holds overwhelmingly stronger evidence, anchored by an indefensible valuation, microscopic revenue, and severe cash burn. The bull case rests almost entirely on speculative future potential, sector hype, and a strong but depleting liquidity position. The single most important tension in the investment debate is whether the company's patented photonics technology can achieve meaningful commercial revenue and scale before its cash runway expires, thereby justifying its current $1.69 billion market cap. The recent 22% monthly bounce appears to be a classic speculative rally within a longer-term downtrend, not a fundamental reversal.
Bullish
- Strong Liquidity, Minimal Debt: The company's balance sheet shows a robust current ratio of 102.4 and a negligible debt-to-equity ratio of 0.001, providing a significant financial runway to fund its R&D efforts without immediate solvency concerns. This strong liquidity position is a critical asset for a pre-revenue company in a capital-intensive sector.
- Sector-Wide Catalysts and Momentum: Recent news of Microsoft's accelerated quantum roadmap and Nvidia's AI for quantum error correction has ignited a speculative rally across the quantum sector, with QUBT participating in a 22.13% surge over the past month. This external validation and heightened investor interest provide a favorable narrative backdrop for the stock.
- Differentiated Room-Temperature Technology: The company's focus on photonics-based quantum hardware designed to operate at room temperature and low power presents a potential cost and scalability advantage over competitors reliant on cryogenic systems. This technological niche could carve out a defensible market position if successfully commercialized.
- Analyst Maintained Buy Ratings: Despite limited coverage, some institutional firms like Rosenblatt and Ascendiant Capital have maintained 'Buy' ratings on the stock as recently as March 2026, indicating a segment of professional opinion sees long-term potential. This provides a counterpoint to the overwhelmingly negative fundamental picture.
Bearish
- Extreme, Unsustainable Valuation: The stock trades at a trailing Price-to-Sales ratio of 2,474.6x, an astronomical figure that prices in decades of hypothetical growth with no fundamental anchor. This valuation is indefensible by any conventional metric and represents extreme speculative froth disconnected from a $198K quarterly revenue base.
- Nascent Revenue and Unproven Model: Revenue is minuscule and highly volatile, with the latest quarter at $198K representing only 2.2% YoY growth and quarterly figures fluctuating wildly between $39K and $384K over the past year. This demonstrates an unproven commercial model still in its earliest, most uncertain stages of development.
- Severe Cash Burn and Deep Losses: The company is burning cash at an alarming rate, with TTM free cash flow of -$36.98 million and a Q4 2025 net loss of $1.56 million. Operating expenses of $22.1 million in Q4 2025 completely dwarf revenue, indicating a heavy and ongoing reliance on external equity financing to fund operations.
- Persistent Long-Term Downtrend: The stock is in a pronounced downtrend, down 42.4% over six months and 21.99% over three months, significantly underperforming the S&P 500. Trading at $8.94, it sits near the lower 34.6% of its 52-week range ($6.18-$25.84), reflecting persistent selling pressure and a lack of sustained bullish conviction.
QUBT Technical Analysis
The stock is in a pronounced long-term downtrend, evidenced by a 42.4% decline over the past six months and a 21.99% drop over the last three months, significantly underperforming the S&P 500's gains of 5.42% and 3.59% over the same periods, respectively. Currently trading at $8.94, the price sits at approximately 34.6% of its 52-week range ($6.18 to $25.84), indicating it is much closer to its yearly lows than highs, which may suggest a value opportunity but also reflects persistent selling pressure and a lack of sustained bullish momentum. Recent momentum shows a sharp but volatile reversal, with the stock up 22.13% over the past month, which strongly diverges from the longer-term downtrend and could signal a potential trend reversal or a short-term, news-driven speculative bounce, as evidenced by the significant price spike from around $6.31 on March 30th to recent levels near $9. Key technical levels are clearly defined, with immediate resistance at the 52-week high of $25.84 and major support at the 52-week low of $6.18; a sustained breakout above the recent high near $10 would be needed to challenge the downtrend, while a breakdown below $6.18 would signal a new leg down. The stock exhibits extreme volatility, with a beta of 3.665, meaning it is approximately 266% more volatile than the broader market, which necessitates outsized risk tolerance and careful position sizing for investors.
Beta
3.67
3.67x market volatility
Max Drawdown
-74.4%
Largest decline past year
52-Week Range
$6-$26
Price range past year
Annual Return
+33.8%
Cumulative gain past year
| Period | QUBT Return | S&P 500 |
|---|---|---|
| 1m | +31.7% | +10.5% |
| 3m | -2.7% | +3.9% |
| 6m | -46.0% | +5.4% |
| 1y | +33.8% | +29.6% |
| ytd | -18.1% | +5.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
QUBT Fundamental Analysis
The company's revenue trajectory is nascent and highly volatile, with the most recent quarterly revenue of $198,000 representing a modest 2.2% year-over-year growth; however, quarterly revenues have fluctuated wildly from $39,000 to $384,000 over the past year, indicating an unproven and inconsistent commercial model that is still in the early stages of development. Profitability remains deeply negative, with a net loss of $1.56 million in Q4 2025 and a gross margin of -49.5% for that quarter, although this represents a significant improvement from the -826.4% net margin in Q4 2024; the path to profitability is uncertain as the company burns cash to fund research and development, with operating expenses of $22.1 million far outstripping revenue in the latest quarter. The balance sheet shows a strong liquidity position with a current ratio of 102.4 and minimal debt, evidenced by a debt-to-equity ratio of 0.001, but this is overshadowed by severe cash burn, with free cash flow over the trailing twelve months at -$36.98 million and operating cash flow of -$11.02 million in the latest quarter, indicating a heavy reliance on external equity financing (common stock issuance of $718.6 million in Q4) to fund operations rather than internal cash generation.
Quarterly Revenue
$198000.0B
2025-12
Revenue YoY Growth
+2.19%
YoY Comparison
Gross Margin
-0.49%
Latest Quarter
Free Cash Flow
$-36984000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is QUBT Overvalued?
Given the company's negative net income, the primary valuation metric selected is the Price-to-Sales (PS) ratio. The trailing PS ratio is an astronomical 2,474.6x, reflecting a market capitalization of $1.69 billion against minuscule revenue, while the forward PS ratio is not calculable from the provided data but would remain stratospheric given estimated revenue of $1.48 billion for a future period appears to be a data anomaly inconsistent with current revenue scale. Compared to industry averages, a PS ratio in the thousands is indefensible by any conventional metric, indicating the stock trades at an extreme, speculative premium that prices in decades of hypothetical future growth with no current fundamental anchor. Historically, the stock's own valuation has been consistently extreme but volatile; its current PS ratio of 2,474.6x is below its Q4 2025 historical reading of 8,417.6x but remains near the top of its multi-year range, suggesting the market continues to price in wildly optimistic expectations for commercial success despite the company's present financial reality.
PE
-90.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -268x~310x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-69.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are severe and center on the company's unsustainable cash burn and lack of revenue scale. With TTM free cash flow of -$36.98 million and quarterly operating expenses of $22.1 million massively outstripping $198K in revenue, the path to profitability is distant and uncertain. The company relies on external equity financing, as evidenced by $718.6 million in common stock issuance in Q4, to fund operations. While the current ratio of 102.4 provides a runway, it is being rapidly consumed by R&D expenses with no guarantee of commercial success.
Market & Competitive Risks are exceptionally high due to the stock's extreme valuation premium and speculative nature. The trailing PS ratio of 2,474.6x leaves the stock vulnerable to catastrophic multiple compression if the quantum hype cycle cools or if the company fails to meet even modest commercial milestones. Competitive disruption from well-funded tech giants like Microsoft, which has its own accelerated quantum roadmap, poses an existential threat. The stock's beta of 3.665 indicates extreme sensitivity to broader market risk-off sentiment, which could trigger a rapid unwind of speculative positions.
Worst-Case Scenario involves a failure to secure additional financing coupled with a continued lack of commercial traction, leading to a liquidity crisis. This could be triggered by a broader sector de-rating, loss of key technical talent, or a significant competitor breakthrough that renders QUBT's technology obsolete. In this adverse scenario, the stock could realistically retest and break below its 52-week low of $6.18, representing a downside of approximately -31% from the current price of $8.94. Given the stock's history and max drawdown of -74.37%, a decline of 50% or more is not implausible if the speculative narrative fully collapses.
FAQ
The key risks are, in order of severity: 1) Valuation Collapse: The extreme PS ratio of 2,474.6x could compress violently if the growth narrative fails, posing a -50%+ downside risk. 2) Commercialization Failure: The company has not proven it can generate scalable revenue, with quarterly sales fluctuating wildly and averaging below $200K. 3) Financial Dilution & Burn: With TTM free cash flow of -$36.98M, the company will likely need to issue more shares, diluting existing holders, to fund operations. 4) Extreme Volatility: A beta of 3.665 means the stock is 266% more volatile than the market, leading to unpredictable and sharp price swings.
Our 12-month outlook presents three scenarios. The Bear Case (60% probability) sees the stock falling to a range of $4-$7 as the speculative bubble deflates and commercial progress stalls. The Base Case (30% probability) envisions a volatile range between $7-$12, driven by sector news rather than fundamentals. The Bull Case (10% probability) projects a surge to $20-$26 on the back of a transformative partnership or contract. The Bear Case is deemed most likely due to the unsustainable valuation and lack of fundamental support. The key assumption is that the company's revenue will remain immaterial relative to its market cap over the next year.
QUBT is profoundly overvalued by any conventional fundamental metric. Its trailing Price-to-Sales ratio of 2,474.6x is astronomically high and indicates the market is pricing in decades of flawless future growth that may never materialize. Compared to its own history, the current PS ratio, while down from 8,417.6x in Q4 2025, remains near the top of its multi-year range. The valuation implies the market expects near-perfect commercial success of its unproven technology, making the stock exceptionally vulnerable to multiple compression if execution falters or sector sentiment cools.
For the vast majority of investors, QUBT is not a good stock to buy. It represents an extreme speculative bet with a valuation (PS ratio of 2,474.6x) completely disconnected from its minuscule $198K quarterly revenue and severe cash burn. The stock has significantly underperformed the market, down 42.4% over six months. It could only be considered a 'good buy' for a very specific type of investor: one with a high-risk tolerance, a long-term horizon, a deep understanding of quantum photonics, and a willingness to allocate a very small portion of their portfolio to a potential moonshot that has a high probability of going to zero.
QUBT is unsuitable for short-term trading for all but the most sophisticated and risk-aware traders due to its extreme volatility (beta 3.665) and news-driven price action. It pays no dividend and has no earnings visibility. As a long-term investment, it is only suitable for investors with a 5-10 year horizon who are betting on the eventual success of its quantum technology, understanding that the company may require significant further dilution and face years of losses before any payoff. There is no middle ground; it is a binary, long-duration speculative asset, not an investment for capital preservation or steady growth.
